MCC-16-MULTI-22-PMC: Pharmacodynamic Effects of Fatty Acid Synthase (FASN) Inhibition with TVB-2640 in Resectable Colon and Other Resectable Cancers: A Window Trial

Grants and Contracts Details

StatusActive
Effective start/end date12/22/167/31/23

Funding

  • 3V Biosciences Incorporated: $25,000.00